Skip to main content
Clinical Trials/NL-OMON48354
NL-OMON48354
Completed
Not Applicable

A Mindfulness-Based Stress Reduction programme in at-risk mutation carriers of genetic frontotemporal dementia - MBSR in presymptomatic FTD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
frontotemporal dementia
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
26
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Asymptomatic, first\-degree relatives of FTD patients due to genetic mutations (MAPT, GRN or C9orf72 genes). They have 50% chance of having the mutation and therefore developing FTD. Age of 18 years and over.

Exclusion Criteria

  • Symptomatic or participants suspect for developing FTD (Clinical Dementia Rating Scale \> 0\.5\).
  • Persons with a previous or other (neurological) condition (e.g. stroke, brain tumour, MS) that may affect cognitive functioning to such a degree that it hampers study participation.
  • Current severe psychiatric conditions (e.g. clinical depression or anxiety disorders).

Outcomes

Primary Outcomes

Not specified

Similar Trials